Shefali Luthra is The 19th’s health reporter covering the intersection of gender and health care. Prior to joining The 19th she was a correspondent at Kaiser Health News, where she spent six years covering national health care and policy.

Posts By This Author

DOJ Accuses Biden Administration of Targeting Christian Anti-Abortion Activists

by Shefali Luthra, The 19th 04-14-2026
Dan Beazley carries a cross as he participates in the annual "March for Life" for the second time since the U.S. Supreme Court overturned the Roe v. Wade abortion decision, in Washington, D.C., Jan. 19, 2024. REUTERS/Amanda Andrade-Rhoades

The Justice Department accused the Biden administration of unfairly prosecuting anti-abortion activists the day after it fired at least four attorneys who were involved in prosecuting those cases.

The accusations come in the first report from the Justice Department’s “Weaponization Working Group,” which has been tasked with going after law enforcement officials who have investigated President Donald Trump, including New York Attorney General Letitia James and former special counsel Jack Smith.

The report defends Trump’s mass pardoning of 23 people who were convicted under the Biden administration for violating the Freedom of Access to Clinic Entrances Act, also known as the FACE Act. The law prohibits obstructing people from entering medical centers and was passed in 1994 after a spate of violence against abortion providers, including the 1993 murder of Dr. David Gunn.

Supreme Court Dismisses Case That Would Have Limited Abortion Pill Access

by Shefali Luthra, The 19th 06-13-2024

A sticker lays on the ground during abortion rights demonstrations outside of the Supreme Court in Washington, D.C. on March 26, 2024 as the high court hears arguments in a case debating access to the abortion medication Mifepristone. Photo by Bryan Olin Dozier/NurPhoto via Reuters.

The Supreme Court has unanimously dismissed a case that would have limited access to mifepristone, one of the two drugs used in a medication abortion. The decision leaves access to the abortion drug unchanged for now.